These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20964254)

  • 1. SNPs in the APM1 gene promoter are associated with adiponectin levels in HIV-infected individuals receiving HAART.
    Trinca JR; Sprinz E; Lazzaretti RK; Hutz MH; Kuhmmer R; de Almeida S; Tibola A; Meirelles GB; Arena-de-Souza RC; Mattevi VS
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):299-305. PubMed ID: 20964254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy.
    Castilhos JK; Sprinz E; Lazzaretti RK; Kuhmmer R; Mattevi VS
    HIV Med; 2015 Sep; 16(8):494-501. PubMed ID: 26111083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART.
    Gasparotto AS; Sprinz E; Lazzaretti RK; Kuhmmer R; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; Ribeiro JP; Mattevi VS
    AIDS; 2012 Jan; 26(1):19-26. PubMed ID: 22011627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.
    Resino S; Palladino C; Lorente R; Micheloud D; Bellón JM; Larru B; Gutiérrez MD; de José MI; Polo R; Muñoz-Fernández MA;
    Pediatr Infect Dis J; 2010 Aug; 29(8):774-7. PubMed ID: 20375850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
    Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy].
    Leszczyszyn-Pynka M; Pynka S; Boroń-Kaczmarska A; Pilarska K
    Endokrynol Pol; 2005; 56(1):19-24. PubMed ID: 16335669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.
    Asensi V; Martín-Roces E; Carton JA; Collazos J; Maradona JA; Alonso A; Medina M; Aburto JM; Martínez E; Rojo C; Bustillo E; Fernández C; Arribas JM
    Clin Infect Dis; 2004 Jul; 39(2):240-7. PubMed ID: 15307034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
    Paruthi J; Gill N; Mantzoros CS
    Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
    Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and adiponectin, but not IL18, are related with insulin resistance in treated HIV-1-infected patients with lipodystrophy.
    Veloso S; Escoté X; Ceperuelo-Mallafré V; López-Dupla M; Peraire J; Viladés C; Domingo P; Castro A; Olona M; Sirvent JJ; Leal M; Vendrell J; Richart C; Vidal F
    Cytokine; 2012 May; 58(2):253-60. PubMed ID: 22364914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality.
    Yang M; Qiu CC; Chen W; Xu LL; Yu M; Xiang HD
    Biomed Environ Sci; 2008 Dec; 21(6):454-9. PubMed ID: 19263799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications.
    Tsiodras S; Perelas A; Wanke C; Mantzoros CS
    J Infect; 2010 Jul; 61(2):101-13. PubMed ID: 20547180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.
    Tarr PE; Telenti A
    Antivir Ther; 2007; 12(7):999-1013. PubMed ID: 18018758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.
    Marzocchetti A; Schwarz J; Di Giambenedetto S; Colafigli M; Bracciale L; Fabbiani M; Fantoni M; Trecarichi E; Cauda R; De Luca A
    AIDS Res Hum Retroviruses; 2011 Dec; 27(12):1299-309. PubMed ID: 21595566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
    Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.